Cargando…
DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway
The histone 3 lysine 79 (H3K79) methyltransferase (HMT) DOT1L is known to play a critical role for growth and survival of MLL-rearranged leukemia. Serendipitous observations during high-throughput drug screens indicated that the use of DOT1L inhibitors might be expandable to multiple myeloma (MM). T...
Autores principales: | Dafflon, Caroline, Gaulis, Swann, Barys, Louise, Kapur, Karen, Cornacchione, Vanessa, Schukur, Lina, Bergling, Sebastian, Traggiai, Elisabetta, Jansky, Selina, Hellmann, Leon, Engstler, Barbara Schacher, Kerr, Grainne, de Weck, Antoine, Ruddy, David A., Naumann, Ulrike, Stauffer, Frédéric, Gaul, Christoph, Lin, Ying, Billy, Eric, Weiss, Andreas, Hofmann, Francesco, Ito, Moriko, Tiedt, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082114/ https://www.ncbi.nlm.nih.gov/pubmed/32215184 http://dx.doi.org/10.18632/oncotarget.27493 |
Ejemplares similares
-
Targeting multiple nodes of MLL complexes to improve leukemia therapy
por: Dafflon, Caroline, et al.
Publicado: (2017) -
The Tyrosine Phosphatase PTPN14 Is a Negative Regulator of YAP Activity
por: Michaloglou, Chrysiis, et al.
Publicado: (2013) -
Synthetic Standards Combined With Error and Bias Correction Improve the Accuracy and Quantitative Resolution of Antibody Repertoire Sequencing in Human Naïve and Memory B Cells
por: Friedensohn, Simon, et al.
Publicado: (2018) -
A distinct p53 target gene set predicts for response to the selective p53–HDM2 inhibitor NVP-CGM097
por: Jeay, Sébastien, et al.
Publicado: (2015) -
Correction: A distinct p53 target gene set predicts for response to the selective p53-HDM2 inhibitor NVP-CGM097
por: Jeay, Sébastien, et al.
Publicado: (2016)